Genenta Science (GNTA)

• Market cap: $15.8M
• 1 day: -2.79%
• 5 days: 0.91%
• 1 month: -21.47%
• 3 months: -53.24%
• 6 months: -79.47%
• Year to date: -52.25%
• 1 year: -81.09%
• 5 years: -93.88%
• 10 years: -93.88%
• Sector: Healthcare
• Industry: Biotechnology

About: Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Employees: 9